| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.09 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.068 | 0.09 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.09 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.1 |